BDTX - Black Diamond Therapeutics Inc
2.27
0.090 3.965%
Share volume: 805,365
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.18
0.09
0.04%
Summary score
24%
Profitability
41%
Dept financing
22%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
11.26%
Return on assets
-6.07%
Return on sales
0%
Return on invested capital
211.15%
Total debt ratio
82.59%
Debt ratio change over timeo
0%
Current Ratio
30.52%
Quick Ratio
0%
Cash Position Ratio
25.63%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
9.14%
Return on assets
-6.12%
Return on sales
0%
Return on invested capital
232.44%
Total debt ratio
70.74%
Debt ratio change over timeo
0%
Current Ratio
33.13%
Quick Ratio
0%
Cash Position Ratio
27.02%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-4.25%
Return on assets
-4.3%
Return on sales
0%
Return on invested capital
-10.79%
Total debt ratio
1.81%
Debt ratio change over time
0%
Current Ratio
33.92%
Quick Ratio
0%
Cash Position Ratio
10.42%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BDTX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 11.26% | 11.55% | 5.76% | 8.53% |
| Return on assets | -6.07% | 3.57% | 4.02% | 5.96% |
| Return on sales | 0% | 42.16% | 39.53% | 45.73% |
| Return on invested capital | 211.15% | 7.99% | 5.61% | 8.26% |
| Profitability | 49% | 64% | 52% | 69% |
| Total debt ratio | 82.59% | 74.11% | 65.71% | 48.2% |
| Debt ratio change over time | 0% | 0% | 376.49% | 4.51% |
| Dept financing | 25% | 22% | 45% | 15% |
| Current Ratio | 33.13% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 27.02% | 0.76% | 2.25% | 1% |
| Liquididy | 50% | 29% | 26% | 19% |
| Short-term ratios | BDTX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 9.14% | 17.94% | -1.29% | 11.66% |
| Return on assets | -6.12% | 3.67% | 1.51% | 6.9% |
| Return on sales | 0% | 37.5% | 16.39% | 50.72% |
| Return on invested capital | 232.44% | 7.17% | -0.65% | 10.66% |
| Profitability | 38% | 58% | 14% | 67% |
| Total debt ratio | 70.74% | 83.42% | 64.86% | 51.93% |
| Debt ratio change over time | 0% | 0% | 1.76% | 4.05% |
| Dept financing | 21% | 25% | 30% | 41% |
| Current Ratio | 33.13% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 27.02% | 0.76% | 2.25% | 1% |
| Liquididy | 50% | 18% | 29% | 18% |